Dysregulation of Tissue Factor, Thrombin-Activatable Fibrinolysis Inhibitor, and Fibrinogen in Patients Undergoing Total Joint ArthroplastyChristopher Wanderling, Jawed Fareed, Elissa Finkler et al.|Clinical and Applied Thrombosis/Hemostasis|2017Cited by 19
Perioperative Factors and Their Effect on the Fibrinolytic System in Arthroplasty PatientsAndrew Burleson, William Hopkinson, Jawed Fareed et al.|Clinical and Applied Thrombosis/Hemostasis|2015Cited by 13
Levels of Matrix-Degrading Enzymes and Lubricin in Patients With Degenerative Joint Disease Requiring ArthroplastyChristopher Wanderling, William Hopkinson, Elissa S. Davis et al.|Clinical and Applied Thrombosis/Hemostasis|2017Cited by 9
Synovial Fluid Analysis in Patients with Osteoarthritis Requiring Total Joint ArthroplastyElissa S. Davis, William Hopkinson, Jawed Fareed et al.|World Journal of Surgery and Surgical Research|2018Cited by 2